CN114377054A - 青钱柳叶或其提取物在制备预防和/或治疗痤疮的药物或化妆品中的用途 - Google Patents
青钱柳叶或其提取物在制备预防和/或治疗痤疮的药物或化妆品中的用途 Download PDFInfo
- Publication number
- CN114377054A CN114377054A CN202011111233.0A CN202011111233A CN114377054A CN 114377054 A CN114377054 A CN 114377054A CN 202011111233 A CN202011111233 A CN 202011111233A CN 114377054 A CN114377054 A CN 114377054A
- Authority
- CN
- China
- Prior art keywords
- cyclocarya paliurus
- acne
- preparation
- mask
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 65
- 241000233779 Cyclocarya paliurus Species 0.000 title claims abstract description 61
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 51
- 239000000284 extract Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 239000002537 cosmetic Substances 0.000 title claims abstract description 20
- 229940079593 drug Drugs 0.000 title claims abstract description 17
- 230000001815 facial effect Effects 0.000 claims abstract description 12
- 208000024891 symptom Diseases 0.000 claims abstract description 10
- 239000006071 cream Substances 0.000 claims abstract description 9
- 206010015150 Erythema Diseases 0.000 claims abstract description 7
- 208000003251 Pruritus Diseases 0.000 claims abstract description 7
- 231100000321 erythema Toxicity 0.000 claims abstract description 7
- 208000035824 paresthesia Diseases 0.000 claims abstract description 6
- 235000013336 milk Nutrition 0.000 claims abstract description 3
- 210000004080 milk Anatomy 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- 230000002757 inflammatory effect Effects 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims description 8
- 206010033733 Papule Diseases 0.000 claims description 7
- 206010037888 Rash pustular Diseases 0.000 claims description 7
- 208000029561 pustule Diseases 0.000 claims description 7
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 6
- 230000037380 skin damage Effects 0.000 claims description 6
- 206010040882 skin lesion Diseases 0.000 claims description 6
- 231100000444 skin lesion Toxicity 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 5
- 229920002125 Sokalan® Polymers 0.000 claims description 5
- 229960001631 carbomer Drugs 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 239000004475 Arginine Substances 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 229920006037 cross link polymer Polymers 0.000 claims description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 4
- -1 polydimethylsiloxane Polymers 0.000 claims description 4
- 229940078492 ppg-17 Drugs 0.000 claims description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 3
- 241001071795 Gentiana Species 0.000 claims description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 3
- 229960000458 allantoin Drugs 0.000 claims description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims description 2
- 240000000982 Malva neglecta Species 0.000 claims description 2
- 235000000060 Malva neglecta Nutrition 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000002910 effect on acne Effects 0.000 abstract description 3
- 238000002474 experimental method Methods 0.000 abstract description 3
- 239000006210 lotion Substances 0.000 abstract description 2
- 239000000686 essence Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000003902 lesion Effects 0.000 description 7
- 238000003756 stirring Methods 0.000 description 6
- 240000004507 Abelmoschus esculentus Species 0.000 description 4
- 235000003934 Abelmoschus esculentus Nutrition 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 241001635598 Enicostema Species 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 241000662429 Fenerbahce Species 0.000 description 2
- 241001135871 Gentiana scabra Species 0.000 description 2
- 206010027626 Milia Diseases 0.000 description 2
- 206010054107 Nodule Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000031513 cyst Diseases 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000020154 Acnes Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000009675 Perioral Dermatitis Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010041303 Solar dermatitis Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006749 inflammatory damage Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了青钱柳叶或其提取物在制备预防和/或治疗痤疮的药物或化妆品中的用途。实验表明,痤疮患者在使用本发明的青钱柳叶面膜后,痤疮个数明显减少,红斑、瘙痒、灼热、刺痛感症状明显改善;本发明的青钱柳叶面膜对痤疮患者的总有效率高达93.75%。因此,本发明制得的青钱柳提取物对痤疮具有显著的治疗效果,在制备预防和/或治疗痤疮的药物或化妆品(包括面膜、洗面奶、护肤水、乳、日霜、晚霜、眼霜、精华)中具有非常好的应用前景。
Description
技术领域
本发明涉及药物或化妆品领域,具体涉及青钱柳叶或其提取物在制备预防和/或治疗痤疮的药物或化妆品中的用途。
背景技术
痤疮为临床上常见的慢性毛囊皮脂腺炎症性皮肤病,中医称之为“肺风粉刺”、“酒刺”等。痤疮一般多发生于青年男女的面部和胸背部,其特征性皮损是与毛囊一致性的丘疹、黑头粉刺、白头粉刺、脓疱、结节等。粉刺进一步发展会演变成各种炎症性皮损,表现为炎性丘疹、脓疱、结节和囊肿等,炎症性皮损消退后常常遗留色素沉着、持久性红斑、凹陷性或肥厚性瘢痕,以致病情顽固、缠绵难愈。痤疮是青年人群中最常见的影响美容的皮肤病,患者容易出现自信心受损、尴尬、抑郁等心理问题,造成社交和就业障碍等。
痤疮发病原因及发病机理较复杂,西医认为这是一种多因素疾病,主要与雄激素、皮脂分泌增加、微生物、炎症损害及免疫、遗传、环境、日常生活习惯等有关。中医认为此病常由内热炽盛、外感风邪所致,按中医辨证分为肺经风热、肠胃湿热、痰瘀互结三型。
目前临床上多采用维A酸类药物、抗生素、激素等治疗痤疮,早期疗效尚可,但对于痤疮后期的囊肿、瘢痕等缺乏疗效,且有多种副作用以及易复发等缺点。中医药对此病疗效突出,但顽固性痤疮因其邪气深痼,口服中药对于局部病变往往治疗周期较长。因此,开发一种安全有效治疗痤疮尤其是顽固性痤疮的产品是痤疮患者的迫切需求。
青钱柳,Cyclocaryapaliurus(Batal.)ljinskaja,又名青钱李、摇钱树、甜茶树等,系胡桃科青钱柳属单种属植物,为我国所特有,属濒危树种。青钱柳是一种高大速生阔叶乔木,因其树形似柳,果实圆形似铜钱,色青而下垂,故名“青钱柳”。据《中国中药资源志要》记载,其树皮、叶具有清热消肿、止痛的功能,可用于治疗顽癣。长期以来,民间用其叶片做茶,因其味甜且具有清热解暑、降血糖、降血压和延年益寿的作用。青钱柳为我国特有的降糖药用植物资源,近年来的青钱柳研究也多集中在降糖药理、药效物质基础等方面。
目前,尚未见青钱柳叶或其提取物在制备治疗痤疮的药物或化妆品中的报道。
发明内容
本发明的目的在于提供青钱柳叶或其提取物在制备预防和/或治疗痤疮的药物或化妆品中的用途。
本发明提供了青钱柳叶或其提取物在制备预防和/或治疗痤疮的药物或化妆品中的用途。
进一步地,所述化妆品为面膜制剂、面膜、洗面奶、护肤水、乳、日霜、晚霜、眼霜或精华。
进一步地,所述药物或化妆品能够减少皮损数量;所述皮损为炎性皮损和/或非炎性皮损,优选为丘疹、脓疱、白头粉刺、黑头粉刺中的一种或多种。
进一步地,所述药物或化妆品能够改善红斑、瘙痒、灼热和/或刺痛感症状。
进一步地,所述青钱柳叶提取物为青钱柳叶水提物或青钱柳叶有机溶剂提取物。
进一步地,所述青钱柳叶水提物的制备方法为:
取青钱柳叶,加水,加热提取,保留提取液,浓缩或干燥,即得。
进一步地,所述水的重量为青钱柳叶的5-30倍;所述加热温度为70-110゜C;所述提取时间为每次0.5-3.0小时;所述提取次数为1-4次;
优选的,所述水的重量为青钱柳叶的10-20倍;所述加热温度为90℃;所述提取时间为每次1.5-2.0小时;所述提取次数为2次。
本发明还提供了一种预防和/或治疗痤疮的面膜制剂,所述面膜制剂是由青钱柳叶或其提取物为活性成分,加上面膜制剂领域常用的辅料制备而成;优选的,所述青钱柳叶提取物如上所述。
进一步地,所述面膜制剂领域常用的辅料为卡波姆、尿囊素、EDTA二钠、甘油、海藻糖、黄原胶、咖啡黄葵果提取物、精氨酸、PEG/PPG-17/6共聚物、聚乙二醇、龙胆根丙二醇提取物、PEG-12聚二甲基硅氧烷交联聚合物、香精中的一种或多种。
本发明还提供了一种预防和/或治疗痤疮的面膜,所述面膜是将面膜纸浸入上述的面膜制剂中后取出制得的。
通过试验证明,痤疮患者在使用本发明的青钱柳叶面膜后,痤疮个数明显减少,红斑、瘙痒、灼热、刺痛感症状明显改善;本发明的青钱柳叶面膜对痤疮患者的总有效率高达93.75%。因此,本发明制得的青钱柳提取物对痤疮具有显著的治疗效果,在制备预防和/或治疗痤疮的药物或化妆品中具有非常好的应用前景。
显然,根据本发明的上述内容,按照本领域的普通技术知识和惯用手段,在不脱离本发明上述基本技术思想前提下,还可以做出其它多种形式的修改、替换或变更。
以下通过实施例形式的具体实施方式,对本发明的上述内容再作进一步的详细说明。但不应将此理解为本发明上述主题的范围仅限于以下的实例。凡基于本发明上述内容所实现的技术均属于本发明的范围。
具体实施方式
本发明所用原料与仪器均为已知产品,通过购买市售产品所得。
其中,青钱柳叶来源于四川南江县光雾山种植基地,经清洗后室温干燥保存。
咖啡黄葵(ABELMOSCHUS ESCLENTUS)果提取物购买于嶅稞新材料科技有限公司(上海,中国)。
PEG/PPG-17/6共聚物购买于Sigma-Aldrich(St Louis,USA)。
聚乙二醇购买于Adamas(上海,中国)。
龙胆(GENTIANA SCABRA)根丙二醇提取物购买于上海同田生物技术股份有限公司(上海,中国)。
PEG-12聚二甲基硅氧烷交联聚合物购买于Adamas(上海,中国)。
10%香精购买于日本东京化成工业株式会社(TCI,Tokyo,Japan),是指浓度为10%(g/mL)的香精。
实施例1、青钱柳叶提取物的制备
取500g青钱柳叶,加15倍重量的水,加热至90゜C提取2次,每次提取1.5h。提取完成后,水提物趁热抽滤,保留滤液,冷却,测定体积为1450mL,即得青钱柳叶水提物。
取250mL上述青钱柳叶水提物于80℃,65r/min下进行减压浓缩,浓缩定容至60mL,得浓度为488mg/ml的青钱柳提取物浓缩液备用(下述实验例2中使用)。
采用紫外-可见分光光度法(《中国药典》2015年版通则0401),以芦丁为对照,测得上述浓缩液中总黄酮浓度为1.25%(w/v,g/mL);以无水葡萄糖为对照,测得浓缩液中总多糖浓度为10.64%(w/v,g/mL)。
实施例2、青钱柳叶面膜制剂的制备
1.将20mL水加入乳化锅中,取卡波姆(Carbomer)0.15g加入乳化锅中,搅拌均匀,待卡波姆均匀的分散在水中后升温至85℃;
2.在搅拌的情况下,在步骤1的体系中加入尿囊素0.15g、EDTA二钠(即乙二胺四乙酸二钠)0.05g、甘油3.0mL、海藻糖1.0g、黄原胶0.15g、咖啡黄葵(ABELMOSCHUS ESCLENTUS)果提取物0.05mL,完全溶解后保温持续搅拌30分钟,然后降温至60℃;
3.在搅拌的情况下,在步骤2的体系中加入精氨酸0.15g,搅拌至完全溶解;
4.降温至室温,在步骤3的体系中加入PEG/PPG-17/6共聚物1.0g,聚乙二醇0.5g,龙胆(GENTIANA SCABRA)根丙二醇提取物0.5mL,PEG-12聚二甲基硅氧烷交联聚合物0.3g,10%香精0.15mL,搅拌均匀;然后用水补足体积至40mL;
5.在步骤4的体系中加入实施例1制得的青钱柳提取物浓缩液60ml,制得青钱柳叶面膜制剂100mL。
实施例3、青钱柳叶面膜的制备
将压缩化妆棉片(233mm×196mm大小)浸入10ml实施例2制得的青钱柳叶面膜制剂中,取出,制得青钱柳叶面膜。
以下通过实验例证明本发明的有益效果。
实验例1、本发明青钱柳叶提取物治疗痤疮的临床效果
1、患者情况
患者性别及年龄范围:入组寻常痤疮患者32例,其中女21例,男11例;平均年龄(27.16±6.56)岁;平均病程(3.75±3.08)年。痤疮综合分级系统(GAGS)评分:15例为轻度,17例为中度,平均GAGS评分为(21.17±4.65)分。
纳入和排除标准:
纳入标准:1.寻常痤疮;2.18~45岁;3.双侧面部病情严重程度基本一致;4.痤疮GAGS评分为轻中度(GAGS评分参照Doshi,A et.al.;Int.J.Dermatol.,36(1997),416-418)。
排除标准:1.治疗部位皮肤破损;2.需要药物辅助治疗;3.对青钱柳提取物过敏;4.有过敏性皮炎、日光性皮炎、口周皮炎、面部皮炎及湿疹等;5.入组两周前曾使用皮质类固醇激素、抗生素、和其它痤疮治疗药物者;6.妊娠或哺乳期;7.有心、肺、肝、肾等器官功能障碍或其他严重疾病患者。
2、疗效评定标准
分别记录患者治疗前后的炎性皮损(丘疹和脓疱)和非炎性皮损(白头粉刺和黑头粉刺)数目,计算皮损改善率=(治疗前皮损总数-治疗后皮损总数)/治疗前皮损总数×100%。痊愈标准:皮损改善率≥90%;
显效标准:皮损改善率60~90%;
有效标准:皮损改善率20~60%;
无效标准:皮损改善率<20%。
总有效率=痊愈率+显效率+有效率
3、治疗方法
患者取仰卧位,清洁面部皮肤后,先对患者的白头粉刺、黑头粉刺、丘疹、脓疱计数,然后将实施例3制得的青钱柳叶面膜平整覆盖在面部患处,开启计时器,等待20分钟后,取下面膜,清水冲洗面部。每次治疗前拍摄患者正面、左侧面及右侧面的照片以作对照,同时仔细观察患者的皮肤反应,询问患者的自觉症状(包括瘙痒、灼热及刺痛感)和发生反应的时间。
隔天治疗一次,总共治疗3周。
4、治疗结果
表1、32个患者治疗过程中的平均痤疮个数比较
白头粉刺 | 黑头粉刺 | 丘疹 | 脓疱 | |
治疗前 | 26.36±19.18 | 6.65±10.31 | 10.63±7.18 | 5.06±4.28 |
第1周治疗后 | 25.16±18.58 | 4.13±5.30 | 9.09±4.26 | 3.96±2.78 |
第2周治疗后 | 16.30±9.08* | 1.21±2.31* | 4.03±2.11 | 0.61±1.07 |
第3周治疗后 | 7.72±6.28* | 0.92±1.23** | 1.30±2.60** | 0.43±0.73 |
表1中:与治疗前相比,*p<0.05;**p<0.01。
表2、32个患者治疗后的疗效统计
治疗结果 | 病例数(例) | 有效率(%) |
痊愈 | 5 | 15.62 |
显效 | 17 | 53.12 |
有效 | 8 | 25 |
无效 | 2 | 6.25 |
表3、32个患者治疗过程中的皮肤反应和自觉症状
表3中:数字表示出现对应症状的患者人数,括号内的比例表示出现对应症状的患者比例。
结果如表1和表2所示。可以看出,痤疮患者在使用本发明的青钱柳叶面膜治疗后,痤疮个数明显减少,特别是白头粉刺、黑头粉刺和丘疹的数量比治疗前显著降低(p<0.05,p<0.01);经3周治疗后,32例患者中,痊愈5例,显效17例,有效8例,无效2例,总有效率高达93.75%。
如表3所示,痤疮患者在使用本发明的青钱柳叶面膜治疗后,红斑、瘙痒、灼热、刺痛感症状也均明显改善。用药期间未见不良反应。
综上,本发明提供了青钱柳叶或其提取物在制备预防和/或治疗痤疮的药物或化妆品中的用途。实验表明,痤疮患者在使用本发明的青钱柳叶面膜后,痤疮个数明显减少,红斑、瘙痒、灼热、刺痛感症状明显改善;本发明的青钱柳叶面膜对痤疮患者的总有效率高达93.75%。因此,本发明制得的青钱柳提取物对痤疮具有显著的治疗效果,在制备预防和/或治疗痤疮的药物或化妆品中具有非常好的应用前景。
Claims (10)
1.青钱柳叶或其提取物在制备预防和/或治疗痤疮的药物或化妆品中的用途。
2.根据权利要求1所述的用途,其特征在于:所述化妆品为面膜制剂、面膜、洗面奶、护肤水、乳、日霜、晚霜、眼霜或精华。
3.根据权利要求1所述的用途,其特征在于:所述药物或化妆品能够减少皮损数量;所述皮损为炎性皮损和/或非炎性皮损,优选为丘疹、脓疱、白头粉刺、黑头粉刺中的一种或多种。
4.根据权利要求1所述的用途,其特征在于:所述药物或化妆品能够改善红斑、瘙痒、灼热和/或刺痛感症状。
5.根据权利要求1~4任一项所述的用途,其特征在于:所述青钱柳叶提取物为青钱柳叶水提物或青钱柳叶有机溶剂提取物。
6.根据权利要求5所述的用途,其特征在于:所述青钱柳叶水提物的制备方法为:
取青钱柳叶,加水,加热提取,保留提取液,浓缩或干燥,即得。
7.根据权利要求6所述的用途,其特征在于:所述水的重量为青钱柳叶的5-30倍;所述加热温度为70-110℃;所述提取时间为每次0.5-3.0小时;所述提取次数为1-4次;
优选的,所述水的重量为青钱柳叶的10-20倍;所述加热温度为90℃;所述提取时间为每次1.5-2.0小时;所述提取次数为2次。
8.一种预防和/或治疗痤疮的面膜制剂,其特征在于:所述面膜制剂是由青钱柳叶或其提取物为活性成分,加上面膜制剂领域常用的辅料制备而成;优选的,所述青钱柳叶提取物如权利要求5~7任一项所述。
9.根据权利要求8所述的面膜制剂,其特征在于:所述面膜制剂领域常用的辅料为卡波姆、尿囊素、EDTA二钠、甘油、海藻糖、黄原胶、咖啡黄葵果提取物、精氨酸、PEG/PPG-17/6共聚物、聚乙二醇、龙胆根丙二醇提取物、PEG-12聚二甲基硅氧烷交联聚合物、香精中的一种或多种。
10.一种预防和/或治疗痤疮的面膜,其特征在于:所述面膜是将面膜纸浸入权利要求8或9所述的面膜制剂中后取出制得的。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011111233.0A CN114377054B (zh) | 2020-10-16 | 2020-10-16 | 青钱柳叶或其提取物在制备预防和/或治疗痤疮的药物或化妆品中的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011111233.0A CN114377054B (zh) | 2020-10-16 | 2020-10-16 | 青钱柳叶或其提取物在制备预防和/或治疗痤疮的药物或化妆品中的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114377054A true CN114377054A (zh) | 2022-04-22 |
CN114377054B CN114377054B (zh) | 2023-08-15 |
Family
ID=81193896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011111233.0A Active CN114377054B (zh) | 2020-10-16 | 2020-10-16 | 青钱柳叶或其提取物在制备预防和/或治疗痤疮的药物或化妆品中的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114377054B (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1520803A (zh) * | 2003-02-12 | 2004-08-18 | 江西省农学会 | 一种护肤组合物 |
JP2008255043A (ja) * | 2007-04-04 | 2008-10-23 | Nippon Menaade Keshohin Kk | 皮膚外用剤 |
JP2011201788A (ja) * | 2010-03-24 | 2011-10-13 | Nippon Menaade Keshohin Kk | 抗炎症剤 |
CN107753552A (zh) * | 2017-10-31 | 2018-03-06 | 无限极(中国)有限公司 | 一种青钱柳叶提取物的制备方法 |
CN108124996A (zh) * | 2018-02-18 | 2018-06-08 | 王俊杰 | 一种改善湿热体质的青钱柳茶及其制备工艺 |
CN108158936A (zh) * | 2018-02-09 | 2018-06-15 | 广西北海苗康生物科技有限公司 | 一种青钱柳珍珠护肤液及制备方法 |
CN109363999A (zh) * | 2018-08-28 | 2019-02-22 | 珠海欧维斯科技有限公司 | 一种负离子护肤组合物及其制备方法和应用 |
-
2020
- 2020-10-16 CN CN202011111233.0A patent/CN114377054B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1520803A (zh) * | 2003-02-12 | 2004-08-18 | 江西省农学会 | 一种护肤组合物 |
JP2008255043A (ja) * | 2007-04-04 | 2008-10-23 | Nippon Menaade Keshohin Kk | 皮膚外用剤 |
JP2011201788A (ja) * | 2010-03-24 | 2011-10-13 | Nippon Menaade Keshohin Kk | 抗炎症剤 |
CN107753552A (zh) * | 2017-10-31 | 2018-03-06 | 无限极(中国)有限公司 | 一种青钱柳叶提取物的制备方法 |
CN108158936A (zh) * | 2018-02-09 | 2018-06-15 | 广西北海苗康生物科技有限公司 | 一种青钱柳珍珠护肤液及制备方法 |
CN108124996A (zh) * | 2018-02-18 | 2018-06-08 | 王俊杰 | 一种改善湿热体质的青钱柳茶及其制备工艺 |
CN109363999A (zh) * | 2018-08-28 | 2019-02-22 | 珠海欧维斯科技有限公司 | 一种负离子护肤组合物及其制备方法和应用 |
Non-Patent Citations (1)
Title |
---|
杨维萍等主编: "《实用临床外科常见病理论与实践》", 科学技术文献出版社 * |
Also Published As
Publication number | Publication date |
---|---|
CN114377054B (zh) | 2023-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10675488B2 (en) | Acne removing skin care product and preparation method thereof | |
CN110769836B (zh) | 预防和治疗痤疮和激素依赖性皮炎的生物多糖及其应用 | |
CN109157451B (zh) | 一种祛痘洁面乳 | |
EA032439B1 (ru) | Композиции и способы для лечения поверхностных ран | |
JP6400851B2 (ja) | ニキビ除去のための医薬組成物とその製造方法 | |
WO2022047862A1 (zh) | 一种生发中药组合物及其制备方法和应用 | |
CN107670027B (zh) | 治疗皮肤病况的组合物和方法 | |
CN111671692A (zh) | 一种祛痘组合物及其制备方法与应用 | |
CN109620879A (zh) | 一种清湿修复膏及其制备方法 | |
CN106727026B (zh) | 一种中药祛痘组合物及其应用 | |
CN114377054B (zh) | 青钱柳叶或其提取物在制备预防和/或治疗痤疮的药物或化妆品中的用途 | |
CN106822321B (zh) | 伤科黄水在制备治疗毛周角化症的药物中的应用 | |
CN113144115A (zh) | 一种治疗寻常疣的中药组合物及其应用 | |
CN117503824B (zh) | 一种修复痤疮瘢痕的纳米组合物及其制备方法 | |
CN114832065B (zh) | 一种治疗痤疮的中药组合物、制剂及其制备方法 | |
CN113995701B (zh) | 一种祛痘和消除痘印的组合物及其制备方法和应用 | |
CN108938757B (zh) | 一种治疗粉刺型痤疮的药物及其制备方法 | |
CN1058178C (zh) | 一种防治痤疮皮肤病的化妆品及其生产方法 | |
CN101185620A (zh) | 一种去除青春蕾并有美容护肤作用的化妆品 | |
CN105288016B (zh) | 一种防治膝骨关节炎外用中药乳剂及其制备方法 | |
CN111544482A (zh) | 一种治疗鼻炎的药物或日化用品 | |
RU2600795C1 (ru) | Композиция растительного происхождения в виде мицеллярного раствора | |
CN111840115A (zh) | 一种基于原花青素低聚体的面部激素依赖性皮炎治疗液及其制备方法 | |
CN117883341A (zh) | 一种具有舒缓作用的金银花美白保湿霜 | |
CN112535708A (zh) | 一种含妥布霉素和中药提取物的凝胶组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |